Related Experiment Video

Updated: Sep 14, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

[A retrospective study of 115 cases of fungal pneumonia]

X Q Xu, S Y Shi, T Z Han

    Zhonghua Nei Ke Za Zhi
    |January 1, 1989
    PubMed

    Insights

    This retrospective study of 115 immunocompromised patients found that fungal pneumonia, often linked to severe liver disease, had a high mortality rate despite antifungal therapies. Incidence increased, with Candida and Aspergillus being common fungal culprits.

    Area of Science:

    • Medical Mycology
    • Infectious Diseases
    • Pulmonology

    Context:

    • Retrospective analysis of 115 immunocompromised patients treated between 1968 and 1986.
    • Significant increase in fungal pneumonia incidence observed, particularly after 1983.
    • Severe liver disease was the predominant underlying condition in 88.7% of cases, with frequent prior antibiotic and corticosteroid use.

    Purpose:

    • To retrospectively analyze cases of fungal pneumonia in immunocompromised patients.
    • To identify common fungal species, clinical features, and pathological findings.
    • To assess treatment outcomes and mortality rates associated with fungal pneumonia in this population.

    Summary:

    • Fungal pneumonia affected 115 immunocompromised patients, predominantly males with severe liver disease. Common fungi included Candida (54.9%) and Aspergillus (36.9%). Key clinical signs were fever, cough, and elevated white blood cell counts.
    • Pathological findings included inflammation, abscesses, vasculitis, infarction, and hemorrhage. Disseminated mycoses were noted in autopsied cases, with extrapulmonary manifestations also observed.
    • Despite various antifungal treatments, the overall mortality rate was high at 80.9%, though survival rates showed a slight improvement in recent years.

    Impact:

    • Highlights the significant burden and high mortality of fungal pneumonia in immunocompromised patients, particularly those with severe liver disease.
    • Provides insights into the epidemiological trends, causative agents, and clinical presentation of fungal pneumonia.
    • Underscores the challenges in treating invasive fungal infections and the need for improved therapeutic strategies and early diagnosis.

    More Related Videos

    Experimental Model to Evaluate Resolution of Pneumonia09:49

    Experimental Model to Evaluate Resolution of Pneumonia

    Published on: February 17, 2023

    Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases03:22

    Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

    Published on: March 1, 2024

    Related Concept Videos

    Pneumonia I: Introduction01:30

    Pneumonia I: Introduction

    Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
    Risk Factors
    Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
    Pneumonia II: Pathophysiology01:29

    Pneumonia II: Pathophysiology

    The pathophysiology of pneumonia involves the following steps:
    Pneumonia III: Complications and Assessment01:30

    Pneumonia III: Complications and Assessment

    Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
    Atypical Pneumonia01:14

    Atypical Pneumonia

    Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
    Cryptococcal Meningitis01:27

    Cryptococcal Meningitis

    Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
    Pneumonia I: Introduction01:29

    Pneumonia I: Introduction

    Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...